^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Thymoma

Related cancers:
11d
Autoantibody repertoire analysis in paraneoplastic pemphigus reveals novel targets linked to mucocutaneous blistering and bronchiolitis obliterans. (PubMed, Commun Med (Lond))
Our findings reveal a disease-defining autoantibody repertoire in paraneoplastic pemphigus that corresponds with clinical manifestations and holds high potential for early cancer detection in patients with blistering disease.
Journal
|
SERPINB3 (Serpin family B member 3)
12d
Establishment of Autoreactive CD4+CD8+ T Cell Hybridomas from Sjögren's Disease Model, SATB1 Conditional Knockout Mice. (PubMed, Int J Mol Sci)
In addition, four out of five clones exhibited upregulated transcription of IL-2 in the salivary glands of T/B cell-deficient RAG2-/- mice, suggesting that autoreactive T cells were enriched in the DP T cell population of SATB1cKO mice. These results suggest that unusual DP T cells in SATB1cKO mice may be involved in autoimmune pathogenesis in SATB1cKO mice.
Preclinical • Journal
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule) • IL2 (Interleukin 2) • SATB1 (SATB Homeobox 1) • TRB (T Cell Receptor Beta Locus)
12d
Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis (clinicaltrials.gov)
P=N/A, N=70, Not yet recruiting, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
New trial
|
cisplatin • doxorubicin hydrochloride
12d
Serum cytokeratin 19 fragment antigen 21-1 as a diagnostic and prognostic biomarker for thymic carcinoma in thymic masses. (PubMed, Eur J Cardiothorac Surg)
CYFRA 21-1 emerges as a reliable diagnostic biomarker for distinguishing TC from other thymic masses. Moreover, it holds promise for prognosis evaluation and potentially for recurrence surveillance.
Journal
|
KRT19 (Keratin 19)
14d
Immune aberrations in thymic epithelial tumors. (PubMed, Mediastinum)
Knowledge of the immune cell composition and the tumor immune microenvironment of TETs is essential to understand the risks of paraneoplastic autoimmunity and treatment-related toxicity in the era of immunotherapy. This review synthesizes recent advances in thymic biology and tumor immunology to frame the immune landscape of TETs.
Review • Journal • IO biomarker
|
PD-L1 (Programmed death ligand 1)
14d
Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma (clinicaltrials.gov)
P2, N=18, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: Dec 2025 --> Dec 2026 | Trial primary completion date: Dec 2025 --> Dec 2026
Trial completion date • Trial primary completion date
|
Erbitux (cetuximab) • cisplatin • doxorubicin hydrochloride • cyclophosphamide
15d
Identification of immune cells in benign and malignant thymus tumors: a Mendelian randomization study. (PubMed, Ann Med Surg (Lond))
Using genetic methodologies, we identified a robust link between immune cells and both benign and malignant thymic tumors. This study highlights the distinct immune phenotypes between benign and malignant thymic tumors, shedding light on their immunological mechanisms and suggesting new avenues for clinical immunotherapy.
Journal
|
CD14 (CD14 Molecule) • CD24 (CD24 Molecule) • CCR2 (C-C Motif Chemokine Receptor 2)
20d
Severe SARS-CoV-2 Infection and Campylobacter coli Bacteremia in a Patient With Good's Syndrome. (PubMed, Cureus)
Additionally, blood cultures grew Campylobacter coli, and she completed a 14-day regimen of azithromycin...At this point, SARS-CoV-2 remained detectable through the multiplex respiratory panel, and inflammatory markers were elevated, with a C-reactive protein of 21.13 mg/dL, procalcitonin of 0.69 ng/mL, and leukocytosis of 11.7 × 10⁹/L with neutrophilia (10.51 × 10⁹/L). This case emphasizes the risk of severe infections in patients with GS, as well as the importance of early detection and comprehensive management of concurrent bacterial and viral infections in immunocompromised individuals.
Journal
|
CRP (C-reactive protein)
22d
Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01) (clinicaltrials.gov)
P=N/A, N=314, Recruiting, Institut Curie | Trial completion date: Dec 2029 --> Dec 2032 | Trial primary completion date: Dec 2028 --> Dec 2031
Trial completion date • Trial primary completion date
28d
Angiomatoid Spindle Cell Thymomas (WHO Type A): An Unusual Histological Subtype That Can Mimic a True Vascular Neoplasm. (PubMed, Int J Surg Pathol)
Clinically, eight patients are alive without recurrence, while two were lost to follow-up. The histopathological features of these spindle cell thymomas represent an unusual subtype that can mimic primary vascular neoplasms, which may require different treatment and have varied outcomes.
Journal
|
CD34 (CD34 molecule) • CD31 (Platelet and endothelial cell adhesion molecule 1) • TP63 (Tumor protein 63) • KRT5 (Keratin 5) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1)
1m
CHEK2 Germline Variants and Their Clinical Implications: Experience from a Turkish Hereditary Cancer Cohort. (PubMed, Cancer Invest)
Recurrent c.470T > C and c.1427C > T variants comprised 41.6% of all cases. Our findings highlight variant- and sex-specific patterns and underscore the relevance of population-based data in refining cancer risk assessment and management of CHEK2 carriers.
Journal
|
CHEK2 (Checkpoint kinase 2)
1m
Clinical characteristics of myasthenia gravis patients with coexistence of AChR and titin antibodies. (PubMed, Front Neurol)
This study provides the first systematic characterization of the clinical profile of AChR-Ab+/Titin-Ab+ myasthenia gravis patients in Southwest China. Our findings indicate that dual antibody-positive MG patients are more prone to generalized disease involvement and have a higher susceptibility to thyroid dysfunction.
Journal
|
TTN (Titin)